New Research Eases Fears About GLP-1 Medications and Thyroid Cancer
For years, people taking GLP-1 receptor agonists (GLP-1 RAs)—such as semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda)—have been warned about a potential risk of…
Category: Research Insights
Global Obesity Trends: Countries with the Highest Obesity Rates (WHO 2022 Data)
Obesity is a growing global health concern, affecting millions of people worldwide. According to the World Health Organization (WHO) 2022…
10 Ways Ayurveda Can Help in Obesity (Medoroga) Management
Obesity (Sthoulya or Medoroga) is considered an imbalance of Kapha and Medo Dhatu (fat tissue) in Ayurveda. It is caused…
The Origins of Obesity: How Did It Come to Earth?
Why Do We Gain Weight So Easily? For most of human history, food scarcity was a bigger threat than overeating.…
The Link Between Abdominal Fat and Cognitive Decline
Belly fat isn’t just a risk for your heart—it could be silently harming your brain. While past research linked visceral…
Eli Lilly’s Mounjaro (Tirzepatide) Targets Emerging Markets: A Game-Changer for Global Obesity?
Eli Lilly and Company, a global pharmaceutical leader, announced plans to launch its blockbuster weight-loss drug Mounjaro (tirzepatide) in emerging markets by…
Anti-Obesity Medications in 2025: A Glimpse into the Future Market
The global anti-obesity medication market is evolving rapidly, with groundbreaking advancements in pharmacological treatments expected to reshape obesity management in…